In vivo and in vitro, 1C-containing Jumonji domains promote M1 macrophage polarization and inhibit the development of glioma xenografts via the miR-302a/METTL3/SOCS2 axis (Zhong et al., 2021). The gene discussed is SOCS2; the disease is central nervous system cancer.